MetLife Investment Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Hold |
14,093
| – | – | ﹤0.01% | 2034 |
|
|
2025
Q1 | $256K | Sell |
14,093
-279
| -2% | -$5.06K | ﹤0.01% | 2069 |
|
|
2024
Q4 | $313K | Buy |
14,372
+433
| +3% | +$9.44K | ﹤0.01% | 2047 |
|
|
2024
Q3 | $382K | Buy |
13,939
+7,854
| +129% | +$215K | ﹤0.01% | 1932 |
|
|
2024
Q2 | $157K | Buy |
+6,085
| New | +$157K | ﹤0.01% | 2387 |
|
|
2020
Q1 | – | Sell |
-641
| Closed | -$155K | – | 2261 |
|
|
2019
Q4 | $155K | Hold |
641
| – | – | ﹤0.01% | 2116 |
|
|
2019
Q3 | $105K | Hold |
641
| – | – | ﹤0.01% | 2292 |
|
|
2019
Q2 | $151K | Buy |
+641
| New | +$151K | ﹤0.01% | 2186 |
|